News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Quest Diagnostics Inc. (DGX) to Speak at the Jefferies and Co. 2013 Global Healthcare Conference


6/5/2013 6:37:03 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MADISON, N.J., June 5, 2013 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that Steve Rusckowski, President and CEO, is scheduled to speak at the Jefferies 2013 Global Healthcare Conference in New York City on Thursday, June 6, 2013 at 1:00 p.m. Eastern Time.

During the conference, Mr. Rusckowski will reaffirm the company's full-year 2013 guidance. Revenues are expected to approximate the prior-year level and diluted earnings per share from continuing operations, before special items, are expected to be between $4.35 and $4.55. Mr. Rusckowski will also provide an update on progress executing the company's five-point strategy and its performance outlook.

The presentation will be webcast live during the conference and will be available to registered investors on the following site: http://wsw.com/webcast/jeff77/dgx/and to the public on www.QuestDiagnostics.com/investor. In addition, the archived webcast will be available one hour after the conclusion of the live event and will remain available until July 6, 2013.

Quest Diagnostics is the world's leading provider of diagnostic information services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at QuestDiagnostics.com.

CONTACT: Investors: Dan Haemmerle, 973-520-2900; Media: Wendy Bost, 973-520-2800

SOURCE Quest Diagnostics Incorporated



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES